Peptide Microarray Market Size To Reach $427.3 Million By 2030

Peptide Microarray Market Growth & Trends

The global peptide microarray market size is expected to reach USD 427.3 million by 2030, registering a CAGR of 6.18% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness a stable growth rate during the forecast period. The technique includes high throughput technologies in the area of clinical assays and proteomics. Peptide microarray can be analyzed through spectroscopy, mass spectrometry, and imaging via fluorescence. It has considerable applications in the field of medicine, pharmacology, and biology. It is one of the automated advanced technologies to collect a large volume of data from an experiment employed for therapeutic discoveries, disease diagnosis, and diagnostic technique development.

The method is employed to identify new drug targets. To detect the antigen present on the protein surface of bacteria, determination of Abs, immunogenic Identification, mapping of the epitope, biomarker validation, serum profiling, enzyme characterization, and HLA profiling are some of the applications of the peptide microarray. The use of peptide microarray for developing diagnostic tests is considered to be an important determinant of industry growth. According to research published in March 2021, peptide microarray can offer significant insights into the antigens for developing the COVID-19-based diagnostic test. Researchers used peptide microarrays to screen the samples for antibodies against the virus. Hence, the development of peptide microarray-based tests is expected to boost industry growth.

For instance, JPT Peptide Technologies commercializes peptide microarray for COVID-19 and infectious conditions at the retail price of USD 324. The technology can be used for immune detection and monitoring, biomarker discovery, and protein interaction validation. Key players are focusing on strategic initiatives to establish a strong distribution network across the globe. For instance, PEPperPRINT GmbH created its presence in the Asia Pacific regional market through distributors such as 4A Biotech Co., Ltd., Filgen, Inc., Tokyo Future Style, Inc., AbClon Inc., Tokyo Future Style Taiwan, Inc., Sciencewerke Co., Ltd., and TrendBio. The company adopted an indirect distribution strategy in the region. The strategy assisted the company to avoid the costs of regulatory compliance and customer acquisitions.

 Request a free sample copy or view report summary: Peptide Microarray Market Report

Peptide Microarray Market Report Highlights

• The instruments type segment is relatively more mature than the services segment and held the largest share in 2023 due to the high number of pharma & biotech companies establishing in-house research stations for antibody-based research

• The disease diagnostics application segment captured the largest revenue share in 2023 owing to the high incidence of infectious diseases in emerging markets. For instance, PEPperPRINT GmbH offers peptide microarray for over 32 infectious conditions

• The pharmaceutical & biotechnology companies end-user segment held the maximum revenue share in 2023 due to the wide use of antibody characterization and validation of protein interactions

• North America accounted for the largest share of the overall revenue in 2023 due to the well-established healthcare facilities in this region along with increased investment in the R&D sector

• The rising awareness among healthcare professionals and patients about the early detection and treatment of chronic diseases also speeds up diagnostic capabilities and boosts the region’s growth

• Moreover, the increasing incidence of diseases, such as chronic and infectious diseases, is encouraging companies to enter the regional market

Peptide Microarray Market Segmentation

Grand View Research has segmented the global peptide microarray market on the basis of type, application, end use, and region:

Peptide Microarray Type Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments

• Reagents

• Services

Peptide Microarray Application Outlook (Revenue, USD Million, 2018 - 2030)

• Disease Diagnostics

• Protein Functional Analysis

• Antibody Characterization

• Drug Discovery

Peptide Microarray End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies

• Hospitals & Clinics

• Diagnostic Centers

• Others

Peptide Microarray Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Peptide Microarray Market

• PEPperPRINT GmbH

• RayBiotech, Inc.

• Creative Biolabs.

• Aurora Biomed Inc.

• Kinexus Bioinformatics Corporation

• Bio-Synthesis Inc.

• Microarrays Inc.

• Arryait Corporation (ARYC).

• JPT Peptide Technologies

• Merck KGaA

• Innopsys

• Nimble Therapeutics, Inc.